Honokiol: A potent chemotherapy candidate for human colorectal carcinoma

Table 2 Effect of honokiol on ascites growth of tumor in Babl/ c nude mice

Group	Ascites	MST(d)	Dead(D)	Living(L)	Survival percentage(L/(D + L) × 100%)
Control	5	10.7	5	0	0%
Honokiol	1	34.3	1	4	80%

MST: Mean survival time. RKO cells were transplanted intraperitoneally. Honokiol was administered 2 mg per mice on d 0, 2, 4, 6, 8, and 10 after tumor transplantation. The mice were monitored for peritoneal bulge and survived for up to 30 d. Control mice died by d 12 of RKO inoculation.